Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that electronic medical record (emr) systems accounted for 2...
Data Insights
Q4 2023 update: electronic medical record (emr) systems related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that electronic medical record (emr) systems accounted for 2 pharmaceutical deals...